Literature DB >> 11413157

TNF and receptors in organ-specific autoimmune disease: multi-layered functioning mirrored in animal models.

G Kassiotis1, G Kollias.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11413157      PMCID： PMC200203          DOI： 10.1172/JCI13362

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  13 in total

Review 1.  On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.

Authors:  G Kollias; E Douni; G Kassiotis; D Kontoyiannis
Journal:  Immunol Rev       Date:  1999-06       Impact factor: 12.988

Review 2.  Regulation of autoimmunity by proinflammatory cytokines.

Authors:  A P Cope
Journal:  Curr Opin Immunol       Date:  1998-12       Impact factor: 7.486

Review 3.  Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

Authors:  M Feldmann; R N Maini
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

4.  The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity.

Authors:  G R Hill; T Teshima; V I Rebel; O I Krijanovski; K R Cooke; Y S Brinson; J L Ferrara
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

5.  Severe inflammatory arthritis and lymphadenopathy in the absence of TNF.

Authors:  I K Campbell; K O'Donnell; K E Lawlor; I P Wicks
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

6.  Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

Authors:  B W van Oosten; F Barkhof; L Truyen; J B Boringa; F W Bertelsmann; B M von Blomberg; J N Woody; H P Hartung; C H Polman
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

7.  Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice.

Authors:  L Mori; S Iselin; G De Libero; W Lesslauer
Journal:  J Immunol       Date:  1996-10-01       Impact factor: 5.422

8.  Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.

Authors:  I S Grewal; K D Grewal; F S Wong; D E Picarella; C A Janeway; R A Flavell
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

9.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response.

Authors:  M Pasparakis; L Alexopoulou; V Episkopou; G Kollias
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

10.  Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination.

Authors:  G Kassiotis; G Kollias
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307
View more
  16 in total

1.  The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia.

Authors:  L A Pasquini; C A Calatayud; A L Bertone Uña; V Millet; J M Pasquini; E F Soto
Journal:  Neurochem Res       Date:  2006-10-25       Impact factor: 3.996

Review 2.  The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.

Authors:  Thomas Hehlgans; Klaus Pfeffer
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

3.  Decreasing TNF-alpha results in less fibrosis and earlier resolution of granulomatous experimental autoimmune thyroiditis.

Authors:  Kemin Chen; Yongzhong Wei; Gordon C Sharp; Helen Braley-Mullen
Journal:  J Leukoc Biol       Date:  2006-10-17       Impact factor: 4.962

Review 4.  Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy.

Authors:  Abbas Mirshafiey; Ghasem Ghalamfarsa; Babak Asghari; Gholamreza Azizi
Journal:  Innov Clin Neurosci       Date:  2014-07

5.  The role of chromogranin B in an animal model of multiple sclerosis.

Authors:  Michelle Mo; Ha Thi Hoang; Stefan Schmidt; Robert B Clark; Barbara E Ehrlich
Journal:  Mol Cell Neurosci       Date:  2013-04-24       Impact factor: 4.314

6.  Tumour necrosis factor receptor 1 and mortality in a multi-ethnic cohort: the Northern Manhattan Study.

Authors:  Jorge M Luna; Yeseon Moon; Khin Liu; Steven Spitalnik; Myunghee Paik; Ralph Sacco; Mitchell S V Elkind
Journal:  Age Ageing       Date:  2013-01-15       Impact factor: 10.668

7.  Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice.

Authors:  Ava J Wu; Hong Hua; Sibyl H Munson; Hugh O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

8.  Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation.

Authors:  K Nissler; D Pohlers; M Hückel; J Simon; R Bräuer; R W Kinne
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

9.  Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs.

Authors:  Soumya D Chakravarty; Guofeng Zhu; Ming C Tsai; Vellore P Mohan; Simeone Marino; Denise E Kirschner; Luqi Huang; Joanne Flynn; John Chan
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

10.  Modulation of experimental autoimmune encephalomyelitis by endogenous annexin A1.

Authors:  Nikolaos Paschalidis; Asif J Iqbal; Francesco Maione; Elisabeth G Wood; Mauro Perretti; Rod J Flower; Fulvio D'Acquisto
Journal:  J Neuroinflammation       Date:  2009-11-13       Impact factor: 8.322
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.